Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.97 USD | -0.43% | +927.15% | +25.84% |
May. 17 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
May. 17 | Sector Update: Health Care | MT |
Financials (USD)
Sales 2024 * | 39.35M | Sales 2025 * | 58.17M | Capitalization | 75.81M |
---|---|---|---|---|---|
Net income 2024 * | -120M | Net income 2025 * | -77M | EV / Sales 2024 * | -1.31 x |
Net cash position 2024 * | 127M | Net cash position 2025 * | 54.53M | EV / Sales 2025 * | 0.37 x |
P/E ratio 2024 * |
-0.7
x | P/E ratio 2025 * |
-1.33
x | Employees | 166 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.02% |
Latest transcript on Marinus Pharmaceuticals, Inc.
1 day | -0.43% | ||
1 week | +927.15% | ||
Current month | +894.25% | ||
1 month | +877.21% | ||
3 months | +46.12% | ||
6 months | +129.76% | ||
Current year | +25.84% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Braunstein
CEO | Chief Executive Officer | 60 | 18-09-04 |
Steven Pfanstiel
DFI | Director of Finance/CFO | 51 | 21-04-11 |
Joseph Hulihan
CTO | Chief Tech/Sci/R&D Officer | 68 | 19-11-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tim Mayleben
BRD | Director/Board Member | 63 | 08-11-30 |
Scott Braunstein
CEO | Chief Executive Officer | 60 | 18-09-04 |
Elan Ezickson
BRD | Director/Board Member | 60 | 19-12-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 1.369 | +4.56% | 17,778 |
24-05-23 | 1.309 | -4.51% | 3,863 |
24-05-22 | 1.371 | +4.51% | 7,626 |
24-05-21 | 1.312 | -3.53% | 400 |
Delayed Quote London S.E., February 04, 2021 at 09:50 am EST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.51% | 727B | |
+31.74% | 594B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.44% | 205B | |
-5.97% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- MRNS Stock
- 0JYL Stock